Table 1

The effect of PGE2 on the expression of MMPs and TIMPs

Extracellular matrix proteinsOther nameFold change*
MMP-1 Collagenase-1 1.96 
MMP-2 Gelatinase A -2.29 
MMP-3 Stromelysin-1 2.51 
MMP-7 Uterine metalloproteinase 2.67 
MMP-8 Collagenase-2 1.36 
MMP-9 Gelatinase B 26.51 
MMP-10 Stromelysin-2 4.89 
MMP-11 Stromelysin-3 3.12 
MMP-12 Metalloelastase -1.01 
MMP-13 Collagenase-3 2.37 
MMP-14 Membrane-type 1 MMP (MT1-MMP) 1.11 
MMP-15 Membrane-type 2 MMP (MT2-MMP) 2.88 
TIMP-1 Tissue inhibitor of metalloproteinase 1 2.58 
TIMP-2 Tissue inhibitor of metalloproteinase 2 1.27 
TIMP-3 Tissue inhibitor of metalloproteinase 3 1.80 
Extracellular matrix proteinsOther nameFold change*
MMP-1 Collagenase-1 1.96 
MMP-2 Gelatinase A -2.29 
MMP-3 Stromelysin-1 2.51 
MMP-7 Uterine metalloproteinase 2.67 
MMP-8 Collagenase-2 1.36 
MMP-9 Gelatinase B 26.51 
MMP-10 Stromelysin-2 4.89 
MMP-11 Stromelysin-3 3.12 
MMP-12 Metalloelastase -1.01 
MMP-13 Collagenase-3 2.37 
MMP-14 Membrane-type 1 MMP (MT1-MMP) 1.11 
MMP-15 Membrane-type 2 MMP (MT2-MMP) 2.88 
TIMP-1 Tissue inhibitor of metalloproteinase 1 2.58 
TIMP-2 Tissue inhibitor of metalloproteinase 2 1.27 
TIMP-3 Tissue inhibitor of metalloproteinase 3 1.80 

Purified CD11c+ bone marrow–derived DCs were stimulated with PGE2 (10−6 M) for 24 hours. RNA was extracted and converted to cDNA. cDNA was diluted according to the manufacturer's instruction and subjected to (RT)2-profiler PCR array. One representative experiment of 3 is shown.

*

Gene expression levels of PGE2-treated DCs divided by gene expression levelsof untreated DCs.

Close Modal

or Create an Account

Close Modal
Close Modal